Drugplain

Dapagliflozin 10 mg/1

Dapagliflozin · TABLET · Zydus Lifesciences Limited

1 Recall on Record
Plain English

Dapagliflozin is a tablet containing dapagliflozin at 10 mg/1, taken oral. Manufactured by Zydus Lifesciences Limited.

Key Facts

Brand Name
Dapagliflozin
Generic Name
Dapagliflozin
NDC Code (Product)
70771-1715
Manufacturer
Zydus Lifesciences Limited
Strength
10 mg/1
Dosage Form
TABLET
Route
ORAL
Marketing Status
Application #
ANDA211582
Drug Class
Sodium-Glucose Cotransporter 2 Inhibitor [EPC]
Marketing Start
04/06/2026

Recall History

1 Recall on Record
Class II03/15/2021

Cardinal Health Inc.

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

TerminatedVoluntary: Firm initiated

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

death3,823 reports
acute kidney injury1,487 reports
off label use1,270 reports
dyspnoea1,269 reports
diarrhoea1,202 reports
nausea1,192 reports
fatigue1,175 reports
dizziness1,111 reports
vomiting1,066 reports
diabetic ketoacidosis987 reports

Frequently Asked Questions

What is Dapagliflozin used for?

Dapagliflozin contains Dapagliflozin. It is a tablet taken oral. Consult your doctor for specific uses.

Is Dapagliflozin a controlled substance?

Dapagliflozin is not classified as a controlled substance by the DEA.

What is the generic name for Dapagliflozin?

The generic name for Dapagliflozin is Dapagliflozin. There are 9 other brand versions of Dapagliflozin.

What is the NDC code for Dapagliflozin 10 mg/1?

The NDC (National Drug Code) for Dapagliflozin 10 mg/1 is 70771-1715, listed by Zydus Lifesciences Limited.